Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.

Announcements

594

Total raised

£887M

disclosed amounts

Pre-Seed
£2.5M

The pre-seed round was led by Tony Mallin MBE of Star Capital alongside Cambridge Enterprise and Cambridge Angels.

"WYA links people with their peers and strengthens the ability to keep contact with those that you’re out with, even when they’ve wandered away and phone signal is limited. Tamzin and the team have been a dream to work with, with a modern eye for developing customer and venue safety through their stunning app"
— James Slater, Venue Operations Manager at The Level (NTSU)
Pre-Seed
£1.6M

The pre-seed round was led by Passion Capital with backing from multiple institutional investors and prominent fintech founders.

"We kept seeing the same thing with high growth company founders—managing finances felt disjointed, with founders juggling too many platforms and tools just to keep track of their cash. Our mission is to make financial management easy, no matter how complex it seems. We’re focused on building a product that founders and CFOs love because it saves them time, protects their funds, and helps them grow their businesses. Our goal is to make financial management as seamless as possible so founders can focus on building their businesses."
— Pac O’Shea, CEO & Co-Founder
Pre-Seed
£1.0M

The pre-seed round was led by YZR Capital to support clinical trials and platform development for eating disorder care.

"The widening gap between the need for care and available resources, along with the lack of personalised treatment options, urgently requires a radical rethink of how eating disorder care is provided. Our goal is to revolutionise care pathways, providing tools that empower clinicians and deliver meaningful results. We aim to keep people out of hospital and enable better long-term recovery while saving costs for the healthcare system. Univa’s platform will augment the overwhelmed clinical workforce by providing evidence-based tools to reach more patients and families, enabling earlier intervention, improved monitoring, and faster recovery."
— Rich Andrews, Co-founder and CEO